Metformin monotherapy in melanoma: a pilot, open-label, prospective, and multicentric study indicates no benefit.

Henri MontaudiéMichael CerezoPhilippe BahadoranCoralie RogerThierry PasseronLaurent MachetJean-Philippe ArnaultLaurence VerneuilEve MaubecFrançois AubinFlorence GranelDamien GiaccheroVéronique HofmanJean-Philippe LacourAllegra MarylineRobert BallottiStéphane Rocchi

Published in: Pigment cell & melanoma research (2017)

Keyphrases

open label
study protocol
clinical trial
phase ii
randomized controlled trial
combination therapy
phase ii study
squamous cell carcinoma
double blind